Table 3.
Treatments received and outcomes in the 2 groups
| Drug | Both | TMA | Non-TMA | P value |
|---|---|---|---|---|
| Treatment | ||||
| Pulse steroid | 115 (58.4%) | 38 (76%) | 77 (52.4%) | 0.010 |
| Cyclophosphamide | 119 (60.4%) | 35 (70%) | 84 (57.1%) | 0.215 |
| MMF | 74 (37.5%) | 15 (30%) | 59 (40.1%) | 0.538 |
| Outcome | ||||
| Death | 13 (6.9%) | 6 (12%) | 7 (4.8%) | 0.100 |
| Failure | 42 (21.5%) | 19 (38%) | 23 (15.9%) | 0.020 |
| Complete response | 93 (47.7%) | 15 (30%) | 78 (53.8%) | 0.005 |
| Partial response | 47 (24.1%) | 10 (20%) | 37 (25.5%) | 0.565 |
MMF, mycophenolate mofetil; TMA, thrombotic microangiopathy.